DATA WAIVER – Buprenorphine Waiver Processing and Support
For the Substance Abuse and Mental Health Services Administration (SAMHSA), DSG operates the DATA Waiver Processing and Support contract.
The work includes 1) maintaining, updating, and improving the Buprenorphine Waiver Notification System (BWNS) and the Buprenorphine Web board; 2) providing support for questions relating to Buprenorphine by telephone or email to physicians, pharmacists, and the general public; 3) maintaining and updating an informational Web site on Buprenorphine, including a physician locator (currently with Project Evolve); 4) monitoring and approving physician discussions on the Buprenorphine Web board; 5) providing ad hoc reporting support to SAMHSA; 6) providing training for SAMHSA; 7) sending announcements to all physicians over a listserv; 8) coordinating and collaborating with the Government Performance Reporting Act contractor to report on outcomes (though the task was never initiated under previous contracts); 9) providing outreach activities to increase the number of physicians who choose to be listed on the locator (neither has this task been initiated under previous contracts); and 10) processing about 3,000 new Notices of Intent Waiver to Prescribe Buprenorphine and treat up to 30 patients, along with about 1,500 second Notices of Intent Waiver to Prescribe Buprenorphine and treat up to a hundred patients.
DSG RESEARCH TEAM
- Principal Investigator Stephen Gies, Ph.D.
- Co-Principal Investigator Nicole Piquero, Ph.D., with the University of Texas at Dallas
- Alex Piquero, Ph.D., with the University of Texas at Dallas
- Jennifer Grotpeter, Ph.D.
- Brandn Green, Ph.D.
- REPORT 1
- REPORT 2
- PRESENTATION 1
- PRESENTATION 2